Capital Bank & Trust CO Sage Therapeutics, Inc. Transaction History

Capital Bank & Trust CO

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$25.95 - $43.15 $690,166 - $1.15 Million
-26,596 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$26.15 - $77.24 $112,235 - $331,514
4,292 Added 19.24%
26,596 $764,000
Q4 2019

Feb 18, 2020
BUY
$60.18 - $154.77 $1.34 Million - $3.45 Million
22,304 New
22,304 $1.61 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Capital Bank & Trust CO Portfolio

Follow Capital Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email